FABP5 and polycystic ovary syndrome: The primary aim of this study was to explore whether abnormal expression of FABP5 in the GCs of PCOS patients is related to the excessive proliferation and impaired fatty acid synthesis of GCs in PCOS patients and to the underlying mechanism involved.